Pathogenic T cells in discoid lupus erythematosus
盘状红斑狼疮中的致病性 T 细胞
基本信息
- 批准号:10664134
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2028-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptive TransferAdvisory CommitteesAffectAfrican AmericanAlopeciaAtrophicAutoimmuneAutoimmune DiseasesBar CodesBiometryBloodBlood specimenBone MarrowCell SeparationCell SurvivalCellsCellular biologyChimera organismChronicCicatrixClonal ExpansionClone CellsCutaneousCytotoxic T-LymphocytesDataDermatologyDevelopmentDiagnosisDiscoid Lupus ErythematosusDiseaseEnvironmentFOXP3 geneFlow CytometryFluorescent in Situ HybridizationFutureGene Expression ProfileGenesGranzymeHead and neck structureHumanHypopigmentationHypoxiaHypoxia Inducible FactorImaging TechniquesImmunobiologyImmunofluorescence ImmunologicImmunologicsImpairmentInfiltrationInflammationInflammatoryInflammatory InfiltrateInjuryKidneyLaboratoriesLesionLupusMapsMediatingModelingMorbidity - disease rateMusNatural Killer CellsPTPRC genePathogenicityPathway interactionsPatientsPhenotypePhysiciansPopulationProductionQuality of lifeRegulatory T-LymphocyteResearchRoleScientistSignal TransductionSiteSkinSkin TissueSystemic Lupus ErythematosusSystemic diseaseT cell infiltrationT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTechniquesTestingTherapeuticTissuesTrainingTranslational ResearchWomanWorkantagonistcareer developmentclinical investigationcomparativecytokinecytotoxiccytotoxicitydraining lymph nodeeffector T cellexhaustiongenetic signaturehypoxia inducible factor 1immune cell infiltratelupus prone micemortalitymouse modelnew therapeutic targetnovelnovel therapeuticspharmacologicprogramsreconstitutionresearch studyresponsesingle-cell RNA sequencingskin damageskin disorderskin lesiontargeted treatmenttissue injurytranscription factortranscriptomicstranslational immunology
项目摘要
PROJECT SUMMARY
Discoid lupus erythematosus (DLE) is a disfiguring autoimmune skin disease with a predilection for affecting
the head and neck that causes permanent scarring, hypopigmentation, and alopecia. DLE disproportionately
affects African American women, and it severely impairs quality of life. DLE may occur alone or in the setting of
systemic lupus erythematosus (SLE), and treatments for DLE are currently unsatisfactory. The DLE
inflammatory infiltrate is predominantly composed of T cells, which appear to promote tissue inflammation and
damage, but how they adapt to the skin environment and subsequently promote tissue injury is unknown. We
recently identified an inflammatory gene program induced by the transcription factor hypoxia inducible factor
(HIF) that is necessary for the survival and effector ability of pathogenic T cells in lupus-prone mice, with a
similar program upregulated in human SLE. Yet, how HIF1 promotes damage and what other tissue adaptation
and effector pathways are activated in skin-infiltrating T cells in DLE are not known. Based on my preliminary
studies, I hypothesize that HIF1 regulates pathogenic T cell survival and effector function in DLE skin, causing
inflammation and damage that may be mediated in part by enhanced cytotoxicity. This HIF1-regulated effector
program also suggests a paradigm of pathogenic adaptation in tissue-infiltrating T cells with the potential to
drive tissue damage. To test my hypothesis, I will determine the mechanism of HIF1 blockade in alleviating
skin disease in a murine lupus model. I will also study human DLE skin and blood samples using single cell
RNA sequencing to probe the developmental trajectory, phenotypic, and functional profile of T cells in human
DLE. Finally, I will use imaging techniques to examine the role of cytotoxicity in tissue damage in human DLE,
with parallel studies in mouse tissue. My studies will not only elucidate the role of HIF1 and cytotoxicity in DLE,
but will also yield the first detailed characterization of infiltrating and circulating T cells in human DLE, paving
the way for future studies to develop and evaluate novel therapeutics for this devastating disease. My proposal
will also support a period of career development during which I will receive additional training in basic and
translational immunology in the laboratory of Dr. Joseph Craft, a leader in the fields of lupus research and T
cell biology. Dr. Craft's laboratory in the Yale Department of Immunobiology provides a highly collaborative and
supportive research environment. To further support my training, I have assembled an advisory committee with
experts in transcriptomic analyses, translational dermatology, cutaneous T cell biology, and autoimmune skin
disease. My research studies and directed additional career development activities focused on computational
approaches, human translational research, and biostatistics in clinical investigation will allow me to
successfully achieve research independence as a physician scientist and open my own laboratory so that I can
use basic and translational immunologic approaches to study cutaneous autoimmune diseases including DLE.
项目摘要
盘状红斑狼疮(DLE)是一种毁容的自身免疫性皮肤疾病,偏爱影响
导致永久性疤痕,不形成和脱发的头颈。不成比例
影响非裔美国妇女,并严重损害生活质量。 DLE可能单独或在
全身性红斑狼疮(SLE)和DLE的处理目前不令人满意。 DLE
炎性浸润主要由T细胞组成,T细胞似乎促进了组织炎症和
损坏,但是它们如何适应皮肤环境并随后促进组织损伤是未知的。我们
最近确定了由转录因子缺氧诱导因子引起的炎症基因程序
(HIF)是狼疮易发的病原T细胞生存和效应子的必要条件,具有A
类似的程序在人SLE中上调。但是,HIF1如何促进损害和其他组织适应
尚不清楚在DLE中浸入皮肤的T细胞中激活效应子途径。根据我的初步
研究,我假设HIF1调节DLE皮肤中的致病性T细胞存活和效应子功能,从而导致
炎症和损害可能部分通过增强的细胞毒性介导。该HIF1调节的效应子
程序还表明,在组织浸入T细胞中的致病性适应范式具有潜力
驱动组织损伤。为了检验我的假设,我将确定HIF1封锁的机制减轻
鼠狼疮模型中的皮肤病。我还将使用单细胞研究人类的皮肤和血液样本
RNA测序以探测人类T细胞的发育轨迹,表型和功能谱
DLE。最后,我将使用成像技术检查细胞毒性在人DLE中组织损伤中的作用,
在小鼠组织中进行平行研究。我的研究不仅会阐明HIF1和细胞毒性在DLE中的作用,
但也将产生人类DLE中浸润和循环T细胞的第一个详细表征,铺路
未来研究开发和评估这种毁灭性疾病的新疗法的方法。我的建议
还将支持一个职业发展时期,在此期间我将接受基本和
约瑟夫·克拉夫特(Joseph Craft)博士的转化免疫学,狼疮研究领域的领导者
细胞生物学。耶鲁大学免疫生物学系的Craft博士实验室提供了高度协作和
支持性研究环境。为了进一步支持我的培训,我已与
转录组分析,翻译皮肤病学,皮肤T细胞生物学和自身免疫性皮肤专家
疾病。我的研究研究并指导了其他职业发展活动,重点是计算
临床研究中的方法,人类翻译研究和生物统计学将使我能够
成功地作为医师科学家实现研究独立性,并开设自己的实验室,以便我可以
使用基本和转化的免疫方法研究包括DLE在内的皮肤自身免疫性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALICIA LITTLE其他文献
ALICIA LITTLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Lung epithelial cell reprogramming by CD4 T cells
CD4 T 细胞对肺上皮细胞进行重编程
- 批准号:
10747632 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Lung epithelial cell reprogramming by CD4 T cells
CD4 T 细胞对肺上皮细胞进行重编程
- 批准号:
10371548 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别:
Lung epithelial cell reprogramming by CD4 T cells
CD4 T 细胞对肺上皮细胞进行重编程
- 批准号:
10545067 - 财政年份:2022
- 资助金额:
$ 17.33万 - 项目类别:
Exosomal-mediated pyroptosis in ventilation-associated preterm brain injury
通气相关早产性脑损伤中外泌体介导的细胞焦亡
- 批准号:
10039670 - 财政年份:2020
- 资助金额:
$ 17.33万 - 项目类别:
The role of COPD genetic risk factor HHIP on lymphocytic inflammation
COPD遗传危险因子HHIP对淋巴细胞炎症的作用
- 批准号:
9891351 - 财政年份:2020
- 资助金额:
$ 17.33万 - 项目类别: